To bad SIP didn't start the buy back now.
Sigma Pharmaceuticals keeps
sliding: down 7.8% in 3 days
Sigma Pharmaceuticals Limited, Australia's 4th
largest pharmaceuticals, biotechnology & life
sciences company by market capitalisation,
extended its slide Tuesday, shedding an
additional 2.30c (or 4.1%) to close at 53.20c. The
shares have tumbled 4.50c (or 7.8%) over the
past three trading days. Compared with the All
Ordinaries Index which fell 83.9 points (or 1.6%)
in the three days, this represented a relative
price change of -6.2%.
We are currently bullish on this stock in the longterm
based on fundamental metrics, but are
more bearish in the short-term based on
technical indicators
What makes us most bullish on the stock is the following:
Price/Earnings of 32.1 versus sector average of 33.2 and
market average of 27.3.
•
"A dividend yield of at least two-thirds the triple-A bond
yield"; the stock's dividend yield is 1.2 times the tripe-A bond
yield of 3.1%.
•
"Current ratio of two or more"; current assets are 2.1 times
current liabilities.
Add to My Watchlist
What is My Watchlist?